bpc 157 for degenerative disc disease BPC-157: Herniation & Lower Back Pain: Canadian Guide Where to inject BPC 157
Description
Made by GlaxoSmithKline (GSK), its approved for severe asthma and some COPD cases
Because of this, peptide therapy requires clinical context
BPC-157 is not FDA-approved, so many physicians do not prescribe it
Similarly, NAD + levels appear reduced in preclinical models of age-associated diseases, including ataxia-telangiectasia (A-T), mitochondrial myopathies, and Alzheimers disease (AD), and disease-matched clinical samples 114,242246
